Respiratory infections are a significant global health threat that contribute to millions of deaths annually. With the increase in international travel and the highly contagious nature of respiratory pathogens, deadly microorganisms such as influenza virus and coronavirus are now able to spread quickly worldwide, resulting in dangerous epidemics. To control the spread of these infections, rapid and accurate detection methods are essential.
The development and validation of any assay starts with the availability of quick, reliable, and reproducible answers. ATCC is here to help with each aspect of assay development with fully sequenced strains, certified reference materials, and quantitative genomic and synthetic molecular standards. Not only are these materials fully authenticated and characterized, they are produced under ISO 9001 certified and ISO/IEC 17025 accredited processes, so you can trust your results and reproduce your data—every time.
Respiratory diagnostics development
Rapid and robust detection methods are essential for containing the spread of dangerous respiratory pathogens and ensuring that infected individuals are treated in a timely manner. For molecular diagnostics manufacturers developing assays for 510(k) premarket submission to the US Food & Drug Administration (FDA), robust testing must be performed to demonstrate that the device is safe and effective as well as substantially equivalent to legally marketed devices. To support these validation studies, ATCC provides an extensive array of authenticated and clinically relevant materials for evaluating limit of detection, inclusivity, and cross-reactivity.
Explore reliable diagnostic toolsResources for featured respiratory pathogens
Influenza research materials
As we face increasing concerns about avian influenza in humans, the need for effective diagnostic tools has never been greater. Stay ahead in the fight against avian influenza with ATCC’s cutting-edge resources. We offer a variety of resources for diagnostics development including synthetic RNA based on key human and avian influenza sequences, genomic RNA, live strains, monoclonal antibodies, and host cell lines.
Explore Influenza ResourcesCoronavirus research materials
We offer biological materials and resources to scientists who are developing novel diagnostics and therapeutics to help detect, study, and treat severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2). Explore our growing collection of genomic and synthetic RNA, heat-inactivated material, monoclonal and polyclonal antibodies, and host cells.
Explore coronavirus controls
